Neutral sphingomyelinase 2 deficiency is associated with lung anomalies similar to emphysema

Mammalian Genome

Volumn 23, Issue 11-12, 2012, Pages 758-763

  Poirier, Christophe ^a   Berdyshev, Evgeny V ^b   Dimitropoulou, Christiana ^a   Bogatcheva, Natalia V ^a   Biddinger, Paul W ^a   Verin, Alexander D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; PROTEIN; SMPD3 PROTEIN; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; DISEASE ASSOCIATION; GENE; GENE MUTATION; LIPID ANALYSIS; LUNG DEVELOPMENT; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG MALFORMATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; RESPIRATORY SYSTEM; SMPD3 GENE; SPHINGOMYELINASE 2 DEFICIENCY; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; CERAMIDES; DNA PRIMERS; GENOTYPE; HISTOLOGICAL TECHNIQUES; LUNG; LUNG COMPLIANCE; MICE; OSTEOGENESIS IMPERFECTA; PHENOTYPE; POLYMERASE CHAIN REACTION; SPHINGOMYELIN PHOSPHODIESTERASE;

MUS;

EID: 84871608339     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-012-9419-x     Document Type: Article

References (26)

1. Aubin I, Adams CP, Opsahl S, Septier D, Bishop CE, Auge N, Salvayre R, Negre-Salvayre A, Goldberg M, Guenet JL, Poirier C (2005) A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nat Genet 37:803-805
2. Berdyshev EV, Gorshkova IA, Usatyuk P, Zhao Y, Saatian B, Hubbard W, Natarajan V (2006) De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells. Cell Signal 18:1779-1792
3. Bonner AE, Lemon WJ, You M (2003) Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis. J Med Genet 40:408-417
4. Bridges JP, Weaver TE (2006) Use of transgenic mice to study lung morphogenesis and function. ILAR J 47:22-31
5. Camp PG, Coxson HO, Levy RD, Pillai SG, Anderson W, Vestbo J, Kennedy SM, Silverman EK, Lomas DA, Pare PD (2009) Sex differences in emphysema and airway disease in smokers. Chest 136:1480-1488
6. Cardoso WV (2000) Lung morphogenesis revisited: old facts, current ideas. Dev Dyn 219:121-130
7. de Torres JP, Casanova C, Pinto-Plata V, Varo N, Restituto P, Cordoba-Lanus E, Baz-Davila R, Aguirre-Jaime A, Celli BR (2011) Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study. PLoS ONE 6:e16021
8. Dimitropoulou C, Drakopanagiotakis F, Chatterjee A, Snead C, Catravas JD (2009) Estrogen replacement therapy prevents airway dysfunction in a murine model of allergen-induced asthma. Lung 187:116-127
9. Filosto S, Castillo S, Danielson A, Franzi L, Khan E, Kenyon N, Last J, Pinkerton K, Tuder R, Goldkorn T (2011) Neutral sphingomyelinase 2: a novel target in cigarette smoke-induced apoptosis and lung injury. Am J Respir Cell Mol Biol 44:350-360
10. Goggel R, Winoto-Morbach S, Vielhaber G, Imai Y, Lindner K, Brade L, Brade H, Ehlers S, Slutsky AS, Schutze S, Gulbins E, Uhlig S (2004) PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. Nat Med 10:155-160
11. Guenet JL, Stanescu R, Maroteaux P, Stanescu V (1981) Fragilitas ossium: a new autosomal recessive mutation in the mouse. J Hered 72:440-441
12. Guilbault C, De Sanctis JB, Wojewodka G, Saeed Z, Lachance C, Skinner TA, Vilela RM, Kubow S, Lands LC, Hajduch M, Matouk E, Radzioch D (2008) Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. Am J Respir Cell Mol Biol 38:47-56
13. Hamai H, Keyserman F, Quittell LM, Worgall TS (2009) Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling. J Lipid Res 50:1101-1108
14. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150
15. Khavandgar Z, Poirier C, Clarke CJ, Li J, Wang N, McKee MD, Hannun YA, Murshed M (2011) A cell-autonomous role for neutral sphingomyelinase 2 in bone mineralization. J Cell Biol 194:277-289
16. Levy M, Khan E, Careaga M, Goldkorn T (2009) Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death. Am J Physiol Lung Cell Mol Physiol 297:L125-L133
17. Longo CA, Tyler D, Mallampalli RK (1997) Sphingomyelin metabolism is developmentally regulated in rat lung. Am J Respir Cell Mol Biol 16:605-612
18. Mariani TJ, Reed JJ, Shapiro SD (2002) Expression profiling of the developing mouse lung: insights into the establishment of the extracellular matrix. Am J Respir Cell Mol Biol 26:541-548
19. Muriel MP, Bonaventure J, Stanescu R, Maroteaux P, Guenet JL, Stanescu V (1991) Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragility. Bone 12:241-248
20. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, Hubbard WC, Berdyshev EV, Tuder RM (2005) Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 11:491-498
21. Poirier C, Yoshiki A, Fujiwara K, Guenet JL, Kusakabe M (2002) Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. Genetics 162:831-840
22. Robbesom AA, Versteeg EM, Veerkamp JH, van Krieken JH, Bulten HJ, Smits HT, Willems LN, van Herwaarden CL, Dekhuijzen PN, van Kuppevelt TH (2003) Morphological quantification of emphysema in small human lung specimens: comparison of methods and relation with clinical data. Mod Pathol 16:1-7
23. Sillence DO, Ritchie HE, Dibbayawan T, Eteson D, Brown K (1993) Fragilitas ossium (fro/fro) in the mouse: a model for a recessively inherited type of osteogenesis imperfecta. Am J Med Genet 45:276-283
24. Teichgraber V, Ulrich M, Endlich N, Riethmuller J, Wilker B, De Oliveira-Munding CC, van Heeckeren AM, Barr ML, von Kurthy G, Schmid KW, Weller M, Tummler B, Lang F, Grassme H, Doring G, Gulbins E (2008) Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 14:382-391
25. Warburton D, Schwarz M, Tefft D, Flores-Delgado G, Anderson KD, Cardoso WV (2000) The molecular basis of lung morphogenesis. Mech Dev 92:55-81
26. Wojewodka G, De Sanctis JB, Radzioch D (2011) Ceramide in cystic fibrosis: a potential new target for therapeutic intervention. J Lipids 2011:674968